Regeneron Pharmaceuticals's Options: A Look at What the Big Money Is Thinking
Regeneron Pharmaceuticals's Options: A Look at What the Big Money Is Thinking
再生元制药公司的期权：看看大额资金在想什么
Deep-pocketed investors have adopted a bullish approach towards Regeneron Pharmaceuticals (NASDAQ:REGN), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in REGN usually suggests something big is about to happen.
资金雄厚的投资者对再生元制药公司（纳斯达克：REGN）采取了看好的态度，这是市场参与者不应忽视的。我们在Benzinga追踪的公开期权记录揭示了这一重要动态。尽管这些投资者的身份仍然未知，但REGN的如此重大举动通常意味着一些大事情即将发生。
We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Regeneron Pharmaceuticals. This level of activity is out of the ordinary.
我们从今天的观察中得知，当Benzinga的期权扫描器突出显示了13个飞凡的期权活动时，获得了这一信息。这样的活动水平非常不寻常。
The general mood among these heavyweight investors is divided, with 46% leaning bullish and 23% bearish...
这些资金雄厚的投资者之间的总...
登录免费看全文
登录/注册
资讯热榜
更新时间